Medroxyprogesterone Acetate
Mostrando 1-12 de 52 artigos, teses e dissertações.
-
1. Quanto tempo após a interrupção do uso de medroxiprogesterona pode ocorrer o retorno da menstruação e da fertilidade?
Após a interrupção do uso da medroxiprogesterona de depósito, a paciente pode ficar em amenorreia por até 1 ano (média de 7 meses). O retorno da fertilidade (ovulação) também pode ser lento, em média 9 meses após a última injeção. Após 10 meses, cerca de 50% das mulheres conseguirá gestar. Entretanto, em uma pequena parcela da população,
Núcleo de Telessaúde Rio Grande do Sul. Publicado em: 12/06/2023
-
2. Quando devemos investigar gravidez antes da reaplicação de medroxiprogesterona trimestral injetável?
Embora os fabricantes da medroxiprogesterona trimestral injetável recomendem como prazo máximo para reaplicação o intervalo de três meses (13 semanas), as evidências disponíveis apontam para segurança anticoncepcional com uso em intervalos de até três meses e 14 dias (15 semanas) sem a necessidade de investigar gravidez.
Se o intervalo de
Núcleo de Telessaúde Rio Grande do Sul. Publicado em: 12/06/2023
-
3. Empowering Adolescent Mothers in the Choice of Contraceptive Methods at the Postpartum Period: Avoiding a Subsequent Pregnancy
Resumo Objetivo Cerca de 80% das gestações na adolescência não são planejadas, e entre 28 e 63% das mães adolescentes apresentam repetição da gravidez em 18 meses. Entre as meninas com gravidez repetida, dois terços relataram que a gravidez não foi planejada. Métodos Estudo observacional retrospectivo realizado na Universidade Estadual de Camp
Rev. Bras. Ginecol. Obstet.. Publicado em: 07/11/2019
-
4. Is the Expression of the Components of the Carotid Matrix of Rats Influenced by Estrogen, Progestin and Tibolone?
Resumo Objetivo Analisar os efeitos do estrogênio isolado ou em combinação com progestogênios e tibolona (TIB) na expressão das metaloproteinases 2 e 9 da matriz extracelular (MMP-2 e MMP-9), da perlecan e da heparanase (HPSE) das paredes vasculares das artérias carótidas. Métodos Trinta ratas Wistar ovariectomizadas com 250 dias de idade foram t
Rev. Bras. Ginecol. Obstet.. Publicado em: 15/08/2019
-
5. Effects of omega-6/3 and omega-9/6 nutraceuticals on pain and fertility in peritoneal endometriosis in rats
Abstract Purpose: To evaluate the effects of the nutraceuticals omega-6/3 and omega-9/6 on endometriosis-associated infertility and pain. Methods: Controlled experimental study, with each group composed of eight female rats. Fertility groups: sham-operated control (0.9% saline solution); control with endometriosis (0.9% saline); omega-6/3 (1.2 g/kg/day);
Acta Cir. Bras.. Publicado em: 06/05/2019
-
6. Dietary intake and eating behavior in depot medroxyprogesterone acetate users: a systematic review
Because of weight gain, women often discontinue hormonal contraception, especially depot medroxyprogesterone acetate (DMPA). Our objective was to conduct a systematic review of studies describing dietary intake or eating behavior in DMPA users to understand whether the use of DMPA is associated with changes in dietary habits and behaviors leading to weight g
Braz J Med Biol Res. Publicado em: 23/04/2018
-
7. Quantification of collagen fibers in canine uteri treated with medroxyprogesterone acetate
ABSTRACT: Collagen plays essential roles in remodeling uterine tissue during decidualization, implantation, pregnancy and involution. To understand whether the progestational agent medroxyprogesterone acetate (MPA) can modify the organization and deposit of collagen in the uteri of normal bitches (Canis Tlupus familiaris), we assessed uterine tissues by hist
Pesq. Vet. Bras.. Publicado em: 2016-12
-
8. Body composition, resting energy expenditure and inflammatory markers: impact in users of depot medroxyprogesterone acetate after 12 months follow-up
ABSTRACT Objective The aim of this study was to evaluate for 12 months the changes of body weight using Depot Medroxyprogesterone Acetate (DMPA) and if these changes are related to inflammatory markers. Subjects and methods Twenty women of childbearing age who chose the DMPA, without previous use of this method, BMI < 30 kg/m2, and 17 women using IUD TCu
Arch. Endocrinol. Metab.. Publicado em: 05/09/2016
-
9. Development of a subcutaneous endometriosis rat model
PURPOSE:To present a rat model of subcutaneous endometriosis for the study of pathophysiology and the effects of drugs.METHODS: Fifty three-month-old female Wistar rats (Rattus norvergicus) were distributed into one control group and four treatment groups: estradiol (2.5; 5; 10mg/kg sc), medroxyprogesterone acetate (0.5; 2; 5mg/kg sc), triptorelin pamoate (0
Acta Cir. Bras.. Publicado em: 2015-01
-
10. Follicle-stimulating hormone to substitute equine chorionic gonadotropin in the synchronization of ovulation in Santa Inês ewes
The substitution of equine chorionic gonadotropin (eCG) by follicle-stimulating hormone (FSH) in protocols for synchronization of ovulation in Santa Inês ewes was assessed. Ten females were submitted to the insertion of intravaginal sponges containing 60 mg medroxyprogesterone acetate for 10 days; after this period sponges were withdrawn and the animals wer
Revista Brasileira de Zootecnia. Publicado em: 2012-03
-
11. Ovarian response of Suffolk ewes to estrous synchronization using short-term protocol
The efficacy of estrus synchronization using short-term protocol was evaluated by ultrasound exams in Suffolk ewes during the pre-breeding season. The control Group (n = 12) was synchronized by treatment for 12 days with vaginal sponges impregnated with medroxyprogesterone acetate, and 400 IU eCG at sponge withdrawal. Experimental groups I, II and III kept t
Revista Brasileira de Zootecnia. Publicado em: 2012-02
-
12. Densidade mineral óssea em usuárias e ex-usuárias do contraceptivo injetável com acetato de medroxiprogesterona de depósito / Bone mineral density in users or ex-users of the injectable contraceptive depot medroxyprogesterone acetate
Objectives: Assess bone mineral density (BMD) in users for at least a year and ex-users in injectable contraceptive postmenopausal with medroxyprogesterone acetate depot (DMPA). Subjects and methods: Two studies have been conducted, both transversal cutting with current users of reproductive age of DMPA and another with postmenopausal women who have used DMP
IBICT - Instituto Brasileiro de Informação em Ciência e Tecnologia. Publicado em: 06/12/2011